On the other hand, Liu et al. (30) identified a novel NF-κB2 mutation in early-onset CVID and reported that NF-κB2 gene mutations are one of the causative agents for this heterogeneous disease (29). This evidence concerns the gene NFKB2 and common variable immunodeficiency.